article thumbnail

LIFE SCIENCES | DAILY NEWS | JUN 11, 2025 | PHARMASHOTS

PharmaShots

Dipanshu dedicatedly covers news ranging from biopharma, life sciences, biotech, and MedTech to diagnostics and animal health companies, FDA, EMA, and biosimilar approvals.

article thumbnail

LIFE SCIENCES | DAILY NEWS | JUN 13, 2025 | PHARMASHOTS

PharmaShots

Dipanshu dedicatedly covers news ranging from biopharma, life sciences, biotech, and MedTech to diagnostics and animal health companies, FDA, EMA, and biosimilar approvals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA’s Revised Draft Guidance on Biological Product Promotion Provides Additional Recommendations/Clarifications

FDA Law Blog: Biosimilars

This Revised Draft Guidance provides considerations for manufacturers, packers or distributors (dubbed “firms”) of prescription biological reference products, biosimilar products, and interchangeable biosimilar products presenting data and information about such products in promotional materials in a truthful and non-misleading way.

article thumbnail

Pipelinepharma marketplace records quadruple growth over a single year

Pharma Mirror

As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. The post Pipelinepharma marketplace records quadruple growth over a single year appeared first on Pharma Mirror Magazine. We are building upon our vision to become the world’s leading B2B pharma product platform.

Dosage 52
article thumbnail

Grail plans FDA filing for cancer blood test after new trial

pharmaphorum

R&D Life Sciences Industry Report - Biologics and Generics The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems. R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research.

article thumbnail

Arecor heads for London Stock Exchange with drug reformulation strategy

pharmaphorum

It builds on the company’s four partnership projects: two with the generics and biosimilars firm Hikma, one with US biotech Inhibrix and another with an unnamed biosimilars partner. Eli Lilly, Novo Nordisk and there’s a group of biosimilar companies who already have a footprint in diabetes.”

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

R&D Life Sciences Industry Report - Biologics and Generics The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems. R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research.